Biodexa Pharmaceuticals Files 6-K Report
Ticker: BDRX · Form: 6-K · Filed: Mar 6, 2025 · CIK: 1643918
| Field | Detail |
|---|---|
| Company | Biodexa Pharmaceuticals PLC (BDRX) |
| Form Type | 6-K |
| Filed Date | Mar 6, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, foreign-private-issuer
TL;DR
Biodexa Pharma (fka Midatech) filed a 6-K on 3/6/25, standard reporting.
AI Summary
Biodexa Pharmaceuticals PLC filed a Form 6-K on March 6, 2025, to report information for the month of March 2025. The company, formerly known as Midatech Pharma Plc, is incorporated in the UK and its principal executive office is located at 1 Caspian Point, Caspian Way, Cardiff, CF10 4DQ. Biodexa Pharmaceuticals PLC is subject to reporting requirements under the 1934 Securities Exchange Act.
Why It Matters
This filing indicates ongoing reporting obligations for Biodexa Pharmaceuticals PLC, providing transparency to investors about the company's regulatory status and corporate information.
Risk Assessment
Risk Level: low — This filing is a routine report of foreign private issuer information and does not contain significant new financial or operational disclosures.
Key Players & Entities
- Biodexa Pharmaceuticals PLC (company) — Filer
- Midatech Pharma Plc (company) — Former company name
- March 2025 (date) — Reporting period
- March 6, 2025 (date) — Filing date
- 1 Caspian Point, Caspian Way, Cardiff, CF10 4DQ (location) — Principal executive office
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information to the SEC.
When was Biodexa Pharmaceuticals PLC formerly known as?
Biodexa Pharmaceuticals PLC was formerly known as Midatech Pharma Plc, with a date of name change on June 2, 2015.
Where is Biodexa Pharmaceuticals PLC's principal executive office located?
The principal executive office is located at 1 Caspian Point, Caspian Way, Cardiff, CF10 4DQ, United Kingdom.
What is the SEC file number for Biodexa Pharmaceuticals PLC?
The SEC file number for Biodexa Pharmaceuticals PLC is 001-37652.
Does Biodexa Pharmaceuticals PLC file annual reports under Form 20-F or 40-F?
Biodexa Pharmaceuticals PLC indicates it files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 6, 2025 regarding Biodexa Pharmaceuticals Plc (BDRX).